Clinical Endocrinology10.1111/cen.145802021963413-418Is thyroid hormone supplementation avoidable for patients with low‐risk papillary thyroid cancer after thyroid lobectomy? A two‐center observational studyLiu Xiao, Jie Wu, Lisha Jiang, Yangmengyuan Xu, Bin Liu,,
VideoEndocrinology10.1089/ve.2022.00052022917-8Optimal Serum Thyroid-Stimulating Hormone Level for Patients with Papillary Thyroid Carcinoma After LobectomyJie Liu,
Endocrinology and Metabolism10.3803/enm.2019.34.2.1502019342150Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid CancerMyung-Chul Lee, Min Joo Kim, Hoon Sung Choi, Sun Wook Cho, Guk Haeng Lee, Young Joo Park, Do Joon Park,,
Thyroid10.1089/thy.2012.0183201222101007-1015Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of RecurrenceJonathan Hugo, Eyal Robenshtok, Ravinder Grewal, Steve Larson, R. Michael Tuttle,
10.21203/ Stimulating Hormone Suppression and Recurrence After Thyroid Lobectomy For Papillary Thyroid CarcinomaMi Rye Bae, Sung Hoon Nam, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim,
Journal of Surgical Oncology10.1002/jso.251642018The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinomaJae Hyun Park, Yu-mi Lee, Yi Ho Lee, Suck Joon Hong, Jong Ho Yoon,
Clinical Thyroidology10.1089/ct.2021;33.281-2842021336281-284Initiation of Thyroid Hormone Replacement Is Common Following Thyroid Lobectomy for Low-Risk Differentiated Thyroid CancerMaria Papaleontiou,
European Thyroid Journal10.1159/00050404720199140-48Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1)Salman Razvi, Vicky Ryan, Lorna Ingoe, Simon H. Pearce, Scott Wilkes,
Frontiers in Endocrinology10.3389/fendo.2020.619841202111The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up StudyYi Dou, Yingji Chen, Daixing Hu, Xinliang Su
Thyroid10.1089/thy.2021.0100202131111662-1672Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 PatientsLin Yan, Mingbo Zhang, Qing Song, Yukun Luo,